Journal Article Review Epublish 29 citations
PubMed: 38248234 DOI: 10.3390/brainsci14010019
Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?
Brain Sci 14(1)
Authors: Carmela Rita Balistreri, Roberto Monastero
Affiliations
- Cellular and Molecular Laboratory, Department of Biomedicine, Neuroscience and Advanced Diagnostics (Bi.N.D.), University of Palermo, 90134 Palermo, Italy.
- Unit of Neurology & Neuro-Physiopathology, Department of Biomedicine, Neuroscience, and Advanced Diagnostics (Bi.N.D), University of Palermo, Via La Loggia 1, 90129 Palermo, Italy.
Abstract
The term "neuroinflammation" defines the typical inflammatory response of the brain closely related to the onset of many neurodegenerative diseases (NDs). Neuroinflammation is well known, but its mechanisms and pathways are not entirely comprehended. Some progresses have been achieved through many efforts and research. Consequently, new cellular and molecular mechanisms, diverse and conventional, are emerging. In listing some of those that will be the subject of our description and discussion, essential are the important roles of peripheral and infiltrated monocytes and clonotypic cells, alterations in the gut-brain axis, dysregulation of the apelinergic system, alterations in the endothelial glycocalyx of the endothelial component of neuronal vascular units, variations in expression of some genes and levels of the encoding molecules by the action of microRNAs (miRNAs), or other epigenetic factors and distinctive transcriptional factors, as well as the role of autophagy, ferroptosis, sex differences, and modifications in the circadian cycle. Such mechanisms can add significantly to understanding the complex etiological puzzle of neuroinflammation and ND. In addition, they could represent biomarkers and targets of ND, which is increasing in the elderly.
MeSH
Micrornas, Brain, Neurodegenerative Diseases
Cited by
- Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease. medRxiv, 2024
- Glutamate gradually elevates [Zn] via the CaM-CaMKII-NOS cascade in primary cultured rat embryonic cortical neurons. Sci Rep, 2025
- Neuroinflammation in Adaptive Immunodeficient Mice with Colitis-like Symptoms. Exp Neurobiol, 2025
- Multi-Faceted Role of Histone Methyltransferase Enhancer of Zeste 2 (EZH2) in Neuroinflammation and Emerging Targeting Options. Biology (Basel), 2025
- Cognitive impairment and vulnerability of cholinergic brain network in the Alzheimer's continuum: free-water imaging based on diffusion tensor imaging. Front Neurosci, 2025
- Neuroinflammation and stress-induced pathophysiology in major depressive disorder: mechanisms and therapeutic implications. Front Cell Neurosci, 2025
- Intraperitoneal Injection of the Outer Membrane Vesicle (OMV) Stimulated Expressions of Neuroinflammatory Markers and Histopathological Changes in the Brains of Adult Zebrafish. Int J Mol Sci, 2024
- Syndecans in Alzheimer's disease: pathogenetic mechanisms and potential therapeutic targets. Neural Regen Res, 2024
- Multi-analyte proteomic analysis identifies blood-based neuroinflammation, cerebrovascular and synaptic biomarkers in preclinical Alzheimer's disease. Mol Neurodegener, 2024
- TREM 2 in Parkinson's Disease: A Promising Candidate Gene for Disease Susceptibility and Progression. Brain Sci, 2025
- Developments in Neurodegenerative Disorders: Highly Cited Articles Published in Brain Sciences in 2023-2024. Brain Sci, 2025
- Shed Syndecans (1-3), ELA-32, BDNF, NLR, and hs-CRP in Parkinson's Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel. Int J Mol Sci, 2025